Sally Adams
Director/Miembro de la Junta en Scancell Ltd. .
Fortuna: 8 792 $ al 30/04/2024
Perfil
Sally Elizabeth Adams is currently a Director & Development Director at Scancell Ltd.
She previously worked as an Executive Director & Chief Development Officer at Scancell Holdings Plc, a Development Director at Neures Ltd., and Head-Neurology & Virology at Ligand UK Ltd.
Adams holds a doctorate from Imperial College London and a graduate degree from the University of Cambridge.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SCANCELL HOLDINGS PLC
0.01% | 19/12/2023 | 78 714 ( 0.01% ) | 8 792 $ | 30/04/2024 |
Cargos activos de Sally Adams
| Empresas | Cargo | Inicio |
|---|---|---|
Scancell Ltd.
 Scancell Ltd. Miscellaneous Commercial ServicesCommercial Services Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Sally Adams.
| Empresas | Cargo | Fin |
|---|---|---|
| SCANCELL HOLDINGS PLC | Director/Miembro de la Junta | 05/02/2024 |
| VERNALIS | Corporate Officer/Principal | - |
| Neures Ltd. | Corporate Officer/Principal | - |
Formación de Sally Adams.
| Imperial College London | Doctorate Degree |
| University of Cambridge | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SCANCELL HOLDINGS PLC | Health Technology |
| Empresas privadas | 3 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
Scancell Ltd.
Scancell Ltd. Miscellaneous Commercial ServicesCommercial Services Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom. | Commercial Services |
| Neures Ltd. |
- Bolsa de valores
- Insiders
- Sally Adams
